Evidence map›Paper›PMID 32625003›Full record

ArticleEngineering in life sciences2019

An electrochemical biosensor for prostate cancer biomarker detection using graphene oxide-gold nanostructures.

Zahra Akbari Jonous, Javad Shabani Shayeh, Fatemeh Yazdian, Amir Yadegari, Mohadeseh Hashemi, Meisam Omidi

Open access · bronzeAbstract read
In one paragraph

Article in Engineering in life sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Zahra Akbari JonousDepartment of Immunology Shahid Sadoughi University of Medical Sciences Yazd Iran.
Javad Shabani ShayehProtein Research Center Shahid Beheshti University GC Tehran Iran.
Fatemeh YazdianDepartment of Life Science Engineering Faculty of New Science and Technologies University of Tehran Tehran Iran.
Amir YadegariProtein Research Center Shahid Beheshti University GC Tehran Iran.
Mohadeseh HashemiBiomedical Engineering Department University of Texas at Austin Austin TX USA.
Meisam OmidiProtein Research Center Shahid Beheshti University GC Tehran Iran.
Shahid Beheshti University · IRShahid Sadoughi University of Medical Sciences and Health Services · IRThe University of Texas at Austin · USUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, a most sensitive electrochemical biosensor for detection of prostate-specific antigen (PSA) was designed. To reach the goal, a sandwich type electrode composed of reduced graphene oxide/ gold nanoparticles (GO/AuNPs), Anti-Total PSA monoclonal antibody, and anti-Free PSA antibody was assembled. The functionalized materials were thoroughly characterized by atomic force microscope spectroscopy, transmission electron microscopy, and X-ray diffraction techniques. The electrochemical properties of each of the modification step were evaluated by cyclic voltammetry and electrochemical impedance spectroscopy. The results presented that the proposed biosensor possesses high sensitivity toward total and free PSA. Furthermore, the fabricated biosensor revealed an excellent selectivity for PSA in comparison to the other tumor markers such as BHCG, Alb, CEA, CA125, and CA19-9. The limit of detection for the proposed electrochemical biosensor was estimated to be around 0.2 and 0.07 ng/mL for total and free PSA antigen, respectively.

Indexed as

biomarkerelectrochemical biosensorprostate cancerprostate specific antigen

Identifiers

PMID32625003
PMCPMC6999480
OpenAlexW2910950002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.